Dataset Viewer
LOINC_NUM
stringlengths 3
8
| COMPONENT
stringlengths 2
246
| PROPERTY
stringlengths 1
29
| TIME_ASPCT
stringlengths 1
15
| SYSTEM
stringlengths 1
106
| SCALE_TYP
stringclasses 10
values | METHOD_TYP
nulllengths 1
57
⌀ | CLASS
stringlengths 2
24
| CLASSTYPE
int64 1
4
| LONG_COMMON_NAME
stringlengths 3
254
| SHORTNAME
nulllengths 2
51
⌀ | EXTERNAL_COPYRIGHT_NOTICE
nulllengths 39
2.6k
⌀ | STATUS
stringclasses 4
values | VersionFirstReleased
stringlengths 1
7
| VersionLastChanged
stringlengths 1
5
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
100002-5
|
Specimen care is maintained
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.PNDS
| 4 |
Specimen care is maintained
| null | null |
ACTIVE
|
2.72
|
2.72
|
100003-3
|
Team communication is maintained throughout care
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.PNDS
| 4 |
Team communication is maintained throughout care
| null | null |
ACTIVE
|
2.72
|
2.72
|
100004-1
|
Demonstrates knowledge of the expected psychosocial responses to the procedure
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.PNDS
| 4 |
Demonstrates knowledge of the expected psychosocial responses to the procedure
| null | null |
ACTIVE
|
2.72
|
2.72
|
100005-8
|
Demonstrates knowledge of nutritional management related to the procedure
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.PNDS
| 4 |
Demonstrates knowledge of nutritional management related to the procedure
| null | null |
ACTIVE
|
2.72
|
2.72
|
100006-6
|
Demonstrates knowledge of medication management
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.PNDS
| 4 |
Demonstrates knowledge of medication management
| null | null |
ACTIVE
|
2.72
|
2.72
|
100007-4
|
Demonstrates knowledge of pain management
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.PNDS
| 4 |
Demonstrates knowledge of pain management
| null | null |
ACTIVE
|
2.72
|
2.72
|
10000-8
|
R wave duration.lead AVR
|
Time
|
Pt
|
Heart
|
Qn
| null |
EKG.MEAS
| 2 |
R wave duration in lead AVR
| null | null |
ACTIVE
|
1.0i
|
2.48
|
100008-2
|
Demonstrates knowledge of wound management
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.PNDS
| 4 |
Demonstrates knowledge of wound management
| null | null |
ACTIVE
|
2.72
|
2.72
|
100009-0
|
Demonstrates knowledge of the procedure and expected results
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.PNDS
| 4 |
Demonstrates knowledge of the procedure and expected results
| null | null |
ACTIVE
|
2.72
|
2.72
|
100010-8
|
No injury related to procedure equipment, medical supplies, or instrumentation
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.PNDS
| 4 |
No injury related to procedure equipment, medical supplies, or instrumentation
| null | null |
ACTIVE
|
2.72
|
2.72
|
100011-6
|
No injury related to an electrical source
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.PNDS
| 4 |
No injury related to an electrical source
| null | null |
ACTIVE
|
2.72
|
2.72
|
100012-4
|
Participates in decisions affecting the patient's plan of care
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.PNDS
| 4 |
Participates in decisions affecting the patient's plan of care
| null | null |
ACTIVE
|
2.72
|
2.72
|
100013-2
|
Participates in the discharge process
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.PNDS
| 4 |
Participates in the discharge process
| null | null |
ACTIVE
|
2.72
|
2.72
|
100014-0
|
Psychosocial health is maintained at or improved from baseline
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.PNDS
| 4 |
Psychosocial health is maintained at or improved from baseline
| null | null |
ACTIVE
|
2.72
|
2.72
|
100015-7
|
No injury related to positioning due to care or procedure
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.PNDS
| 4 |
No injury related to positioning due to care or procedure
| null | null |
ACTIVE
|
2.72
|
2.72
|
10001-6
|
R wave duration.lead I
|
Time
|
Pt
|
Heart
|
Qn
| null |
EKG.MEAS
| 2 |
R wave duration in lead I
| null | null |
ACTIVE
|
1.0i
|
2.48
|
100016-5
|
No injury related to a laser source
|
Find
|
Pt
|
^Patient
|
Ord
| null |
SURVEY.PNDS
| 4 |
No injury related to a laser source
| null | null |
ACTIVE
|
2.72
|
2.72
|
100017-3
|
Perioperative nursing data set outcomes panel
|
-
|
Pt
|
^Patient
|
-
| null |
PANEL.SURVEY.PNDS
| 4 |
Perioperative nursing data set outcomes panel [PNDS]
| null | null |
ACTIVE
|
2.72
|
2.72
|
100018-1
|
Note
|
Find
|
Pt
|
{Setting}
|
Doc
| null |
DOC.ONTOLOGY
| 2 |
Hospice care Note
| null | null |
ACTIVE
|
2.72
|
2.72
|
100019-9
|
ALK gene targeted mutation analysis
|
Prid
|
Pt
|
Bld/Tiss
|
Nom
| null |
MOLPATH.MUT
| 1 |
ALK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
| null | null |
ACTIVE
|
2.72
|
2.72
|
100020-7
|
GNA11 gene targeted mutation analysis
|
Prid
|
Pt
|
Bld/Tiss
|
Nom
| null |
MOLPATH.MUT
| 1 |
GNA11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
| null | null |
ACTIVE
|
2.72
|
2.72
|
100021-5
|
GNAQ gene targeted mutation analysis
|
Prid
|
Pt
|
Bld/Tiss
|
Nom
| null |
MOLPATH.MUT
| 1 |
GNAQ gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
| null | null |
ACTIVE
|
2.72
|
2.72
|
100022-3
|
IDH1 gene targeted mutation analysis
|
Prid
|
Pt
|
Bld/Tiss
|
Nom
| null |
MOLPATH.MUT
| 1 |
IDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
| null | null |
ACTIVE
|
2.72
|
2.72
|
100023-1
|
IDH2 gene targeted mutation analysis
|
Prid
|
Pt
|
Bld/Tiss
|
Nom
| null |
MOLPATH.MUT
| 1 |
IDH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
| null | null |
ACTIVE
|
2.72
|
2.72
|
10002-4
|
R wave duration.lead II
|
Time
|
Pt
|
Heart
|
Qn
| null |
EKG.MEAS
| 2 |
R wave duration in lead II
| null | null |
ACTIVE
|
1.0i
|
2.48
|
100024-9
|
SETBP1 gene targeted mutation analysis
|
Prid
|
Pt
|
Bld/Tiss
|
Nom
| null |
MOLPATH.MUT
| 1 |
SETBP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
| null | null |
ACTIVE
|
2.72
|
2.72
|
100025-6
|
SRSF2 gene targeted mutation analysis
|
Prid
|
Pt
|
Bld/Tiss
|
Nom
| null |
MOLPATH.MUT
| 1 |
SRSF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
| null | null |
ACTIVE
|
2.72
|
2.72
|
100026-4
|
MET gene targeted mutation analysis
|
Prid
|
Pt
|
Bld/Tiss
|
Nom
| null |
MOLPATH.MUT
| 1 |
MET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
| null | null |
ACTIVE
|
2.72
|
2.72
|
100027-2
|
SMAD4 gene targeted mutation analysis
|
Prid
|
Pt
|
Bld/Tiss
|
Nom
| null |
MOLPATH.MUT
| 1 |
SMAD4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
| null | null |
ACTIVE
|
2.72
|
2.72
|
100028-0
|
FBXW7 gene targeted mutation analysis
|
Prid
|
Pt
|
Bld/Tiss
|
Nom
| null |
MOLPATH.MUT
| 1 |
FBXW7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
| null | null |
ACTIVE
|
2.72
|
2.72
|
100029-8
|
Cancer related multigene analysis
|
Find
|
Pt
|
Plas.cfDNA
|
Doc
| null |
MOLPATH
| 1 |
Cancer related multigene analysis in Plasma cell-free DNA by Molecular genetics method
| null | null |
ACTIVE
|
2.72
|
2.72
|
100030-6
|
Axis I: Temporal aspects score
|
Score
|
Pt
|
^Patient
|
Qn
| null |
SURVEY.PAIN
| 4 |
Axis I: Temporal aspects score [Mainz Pain Staging System]
| null | null |
ACTIVE
|
2.72
|
2.72
|
100031-4
|
Axis II: Spatial aspects score
|
Score
|
Pt
|
^Patient
|
Qn
| null |
SURVEY.PAIN
| 4 |
Axis II: Spatial aspects score [Mainz Pain Staging System]
| null | null |
ACTIVE
|
2.72
|
2.72
|
10003-2
|
R wave duration.lead III
|
Time
|
Pt
|
Heart
|
Qn
| null |
EKG.MEAS
| 2 |
R wave duration in lead III
| null | null |
ACTIVE
|
1.0i
|
2.48
|
100032-2
|
Axis III: Drug taking behavior score
|
Score
|
Pt
|
^Patient
|
Qn
| null |
SURVEY.PAIN
| 4 |
Axis III: Drug taking behavior score [Mainz Pain Staging System]
| null | null |
ACTIVE
|
2.72
|
2.72
|
100033-0
|
Axis IV: Utilization of the health care system score
|
Score
|
Pt
|
^Patient
|
Qn
| null |
SURVEY.PAIN
| 4 |
Axis IV: Utilization of the health care system score [Mainz Pain Staging System]
| null | null |
ACTIVE
|
2.72
|
2.72
|
100034-8
|
Provider of automated external defibrillator use
|
Type
|
Pt
|
^Patient
|
Nom
| null |
TRAUMA
| 2 |
Provider of automated external defibrillator use
| null | null |
ACTIVE
|
2.72
|
2.72
|
100035-5
|
Exam finding location
|
Find
|
Pt
|
Chest
|
Nom
| null |
H&P.PX
| 2 |
Exam finding location of Chest
| null | null |
ACTIVE
|
2.72
|
2.72
|
100036-3
|
Exam finding location
|
Find
|
Pt
|
Lung
|
Nom
| null |
H&P.PX
| 2 |
Exam finding location of Lung
| null | null |
ACTIVE
|
2.72
|
2.72
|
100037-1
|
Patient contact disposition
|
Type
|
Pt
|
EMS unit
|
Nom
| null |
TRAUMA
| 2 |
Patient contact disposition EMS unit
| null | null |
ACTIVE
|
2.72
|
2.72
|
100038-9
|
Patient evaluation disposition
|
Type
|
Pt
|
EMS unit
|
Nom
| null |
TRAUMA
| 2 |
Patient evaluation disposition EMS unit
| null | null |
ACTIVE
|
2.72
|
2.72
|
100039-7
|
Crew disposition for patient care
|
Type
|
Pt
|
EMS unit
|
Nom
| null |
TRAUMA
| 2 |
Crew disposition for patient care EMS unit
| null | null |
ACTIVE
|
2.72
|
2.72
|
10004-0
|
R wave duration.lead V1
|
Time
|
Pt
|
Heart
|
Qn
| null |
EKG.MEAS
| 2 |
R wave duration in lead V1
| null | null |
ACTIVE
|
1.0i
|
2.48
|
100040-5
|
Patient transport disposition
|
Type
|
Pt
|
EMS unit
|
Nom
| null |
TRAUMA
| 2 |
Patient transport disposition EMS unit
| null | null |
ACTIVE
|
2.72
|
2.72
|
100041-3
|
Aminoglycoside
|
Susc
|
Pt
|
Isolate
|
OrdQn
| null |
ABXBACT
| 1 |
Aminoglycoside [Susceptibility]
| null | null |
ACTIVE
|
2.72
|
2.72
|
100042-1
|
Atovaquone
|
Susc
|
Pt
|
Isolate
|
OrdQn
| null |
ABXBACT
| 1 |
Atovaquone [Susceptibility]
| null | null |
ACTIVE
|
2.72
|
2.72
|
100043-9
|
Azithromycin+Ethambutol
|
Susc
|
Pt
|
Isolate
|
OrdQn
| null |
ABXBACT
| 1 |
Azithromycin+Ethambutol [Susceptibility]
| null | null |
ACTIVE
|
2.72
|
2.72
|
100044-7
|
Cefcapene
|
Susc
|
Pt
|
Isolate
|
OrdQn
| null |
ABXBACT
| 1 |
Cefcapene [Susceptibility]
| null | null |
ACTIVE
|
2.72
|
2.72
|
100045-4
|
Cefozopran
|
Susc
|
Pt
|
Isolate
|
OrdQn
| null |
ABXBACT
| 1 |
Cefozopran [Susceptibility]
| null | null |
ACTIVE
|
2.72
|
2.72
|
100046-2
|
Cefquinome
|
Susc
|
Pt
|
Isolate
|
OrdQn
| null |
ABXBACT
| 1 |
Cefquinome [Susceptibility]
| null | null |
ACTIVE
|
2.72
|
2.72
|
100047-0
|
Cefteram
|
Susc
|
Pt
|
Isolate
|
OrdQn
| null |
ABXBACT
| 1 |
Cefteram [Susceptibility]
| null | null |
ACTIVE
|
2.72
|
2.72
|
100048-8
|
Clarithromycin+Ethambutol
|
Susc
|
Pt
|
Isolate
|
OrdQn
| null |
ABXBACT
| 1 |
Clarithromycin+Ethambutol [Susceptibility]
| null | null |
ACTIVE
|
2.72
|
2.72
|
100049-6
|
Eravacycline
|
Susc
|
Pt
|
Isolate
|
OrdQn
| null |
ABXBACT
| 1 |
Eravacycline [Susceptibility]
| null | null |
ACTIVE
|
2.72
|
2.72
|
100050-4
|
Erythromycin+Ethambutol
|
Susc
|
Pt
|
Isolate
|
OrdQn
| null |
ABXBACT
| 1 |
Erythromycin+Ethambutol [Susceptibility]
| null | null |
ACTIVE
|
2.72
|
2.72
|
100051-2
|
Ethambutol+rifAMPin
|
Susc
|
Pt
|
Isolate
|
OrdQn
| null |
ABXBACT
| 1 |
Ethambutol+rifAMPin [Susceptibility]
| null | null |
ACTIVE
|
2.72
|
2.72
|
100052-0
|
Flomoxef
|
Susc
|
Pt
|
Isolate
|
OrdQn
| null |
ABXBACT
| 1 |
Flomoxef [Susceptibility]
| null | null |
ACTIVE
|
2.72
|
2.72
|
100053-8
|
Fluoroquinolone
|
Susc
|
Pt
|
Isolate
|
OrdQn
| null |
ABXBACT
| 1 |
Fluoroquinolone [Susceptibility]
| null | null |
ACTIVE
|
2.72
|
2.72
|
100054-6
|
Gamithromycin
|
Susc
|
Pt
|
Isolate
|
OrdQn
| null |
ABXBACT
| 1 |
Gamithromycin [Susceptibility]
| null | null |
ACTIVE
|
2.72
|
2.72
|
100055-3
|
Optochin
|
Susc
|
Pt
|
Isolate
|
OrdQn
| null |
ABXBACT
| 1 |
Optochin [Susceptibility]
| null | null |
ACTIVE
|
2.72
|
2.72
|
100056-1
|
Panipenem
|
Susc
|
Pt
|
Isolate
|
OrdQn
| null |
ABXBACT
| 1 |
Panipenem [Susceptibility]
| null | null |
ACTIVE
|
2.72
|
2.72
|
10005-7
|
R wave duration.lead V2
|
Time
|
Pt
|
Heart
|
Qn
| null |
EKG.MEAS
| 2 |
R wave duration in lead V2
| null | null |
ACTIVE
|
1.0i
|
2.48
|
100057-9
|
Prothionamide
|
Susc
|
Pt
|
Isolate
|
OrdQn
| null |
ABXBACT
| 1 |
Prothionamide [Susceptibility]
| null | null |
ACTIVE
|
2.72
|
2.72
|
100058-7
|
Prulifloxacin
|
Susc
|
Pt
|
Isolate
|
OrdQn
| null |
ABXBACT
| 1 |
Prulifloxacin [Susceptibility]
| null | null |
ACTIVE
|
2.72
|
2.72
|
100059-5
|
Rifapentine
|
Susc
|
Pt
|
Isolate
|
OrdQn
| null |
ABXBACT
| 1 |
Rifapentine [Susceptibility]
| null | null |
ACTIVE
|
2.72
|
2.72
|
100060-3
|
Tildipirosin
|
Susc
|
Pt
|
Isolate
|
OrdQn
| null |
ABXBACT
| 1 |
Tildipirosin [Susceptibility]
| null | null |
ACTIVE
|
2.72
|
2.72
|
100061-1
|
Tosufloxacin
|
Susc
|
Pt
|
Isolate
|
OrdQn
| null |
ABXBACT
| 1 |
Tosufloxacin [Susceptibility]
| null | null |
ACTIVE
|
2.72
|
2.72
|
100062-9
|
Standard Dermatology Outcome Measures panel
|
-
|
Pt
|
^Patient
|
-
| null |
PANEL.CLIN
| 2 |
Standard Dermatology Outcome Measures panel
| null | null |
ACTIVE
|
2.72
|
2.72
|
100063-7
|
Primary skin concern
|
Find
|
Pt
|
^Patient
|
Nom
| null |
CLIN
| 2 |
Primary skin concern
| null | null |
ACTIVE
|
2.72
|
2.72
|
100064-5
|
Itch severity
|
Find
|
RptPeriod
|
^Patient
|
Ord
| null |
CLIN
| 2 |
Itch severity Reporting Period - Reported
| null | null |
ACTIVE
|
2.72
|
2.72
|
10006-5
|
R wave duration.lead V3
|
Time
|
Pt
|
Heart
|
Qn
| null |
EKG.MEAS
| 2 |
R wave duration in lead V3
| null | null |
ACTIVE
|
1.0i
|
2.48
|
100065-2
|
Satisfied with treatment
|
Find
|
Pt
|
^Patient
|
Ord
| null |
CLIN
| 2 |
Satisfied with treatment
| null | null |
ACTIVE
|
2.72
|
2.72
|
100066-0
|
Specular microscopy panel
|
-
|
Pt
|
Eye
|
-
| null |
PANEL.EYE
| 2 |
Specular microscopy panel
| null | null |
TRIAL
|
2.72
|
2.72
|
100067-8
|
Image magnification
|
Len
|
Pt
|
Eye
|
Qn
| null |
EYE.SPECULAR MICROSCOPY
| 2 |
Eye Image magnification
| null | null |
TRIAL
|
2.72
|
2.72
|
100068-6
|
Fixation point
|
Angle
|
Pt
|
Eye.right
|
Nom
| null |
EYE.SPECULAR MICROSCOPY
| 2 |
Right eye Fixation point [Angle]
| null | null |
TRIAL
|
2.72
|
2.72
|
100069-4
|
Fixation point
|
Angle
|
Pt
|
Eye.left
|
Nom
| null |
EYE.SPECULAR MICROSCOPY
| 2 |
Left eye Fixation point [Angle]
| null | null |
TRIAL
|
2.72
|
2.72
|
100070-2
|
Cell density
|
Naric
|
Pt
|
Cornea.right
|
Qn
| null |
EYE.SPECULAR MICROSCOPY
| 2 |
Right cornea Cell density
| null | null |
TRIAL
|
2.72
|
2.72
|
100071-0
|
Cell density
|
Naric
|
Pt
|
Cornea.left
|
Qn
| null |
EYE.SPECULAR MICROSCOPY
| 2 |
Left cornea Cell density
| null | null |
TRIAL
|
2.72
|
2.72
|
100072-8
|
Coefficient of variation
|
ArLen
|
Pt
|
Cornea.right
|
Qn
| null |
EYE.SPECULAR MICROSCOPY
| 2 |
Right cornea Coefficient of variation
| null | null |
TRIAL
|
2.72
|
2.72
|
10007-3
|
R wave duration.lead V4
|
Time
|
Pt
|
Heart
|
Qn
| null |
EKG.MEAS
| 2 |
R wave duration in lead V4
| null | null |
ACTIVE
|
1.0i
|
2.48
|
100073-6
|
Coefficient of variation
|
ArLen
|
Pt
|
Cornea.left
|
Qn
| null |
EYE.SPECULAR MICROSCOPY
| 2 |
Left cornea Coefficient of variation
| null | null |
TRIAL
|
2.72
|
2.72
|
100074-4
|
Hexagonality
|
RelRto
|
Pt
|
Cornea.right
|
Qn
| null |
EYE.SPECULAR MICROSCOPY
| 2 |
Right cornea Hexagonality
| null | null |
TRIAL
|
2.72
|
2.72
|
100075-1
|
Hexagonality
|
RelRto
|
Pt
|
Cornea.left
|
Qn
| null |
EYE.SPECULAR MICROSCOPY
| 2 |
Left cornea Hexagonality
| null | null |
TRIAL
|
2.72
|
2.72
|
100076-9
|
Endothelial cells counted
|
Num
|
Pt
|
Cornea.right
|
Qn
| null |
EYE.SPECULAR MICROSCOPY
| 2 |
Right cornea Endothelial cells counted
| null | null |
TRIAL
|
2.72
|
2.72
|
100077-7
|
Endothelial cells counted
|
Num
|
Pt
|
Cornea.left
|
Qn
| null |
EYE.SPECULAR MICROSCOPY
| 2 |
Left cornea Endothelial cells counted
| null | null |
TRIAL
|
2.72
|
2.72
|
100078-5
|
Endothelial cell area.min
|
Area
|
Pt
|
Cornea.right
|
Qn
| null |
EYE.SPECULAR MICROSCOPY
| 2 |
Right cornea Endothelial cell area.min
| null | null |
TRIAL
|
2.72
|
2.72
|
100079-3
|
Endothelial cell area.min
|
Area
|
Pt
|
Cornea.left
|
Qn
| null |
EYE.SPECULAR MICROSCOPY
| 2 |
Left cornea Endothelial cell area.min
| null | null |
TRIAL
|
2.72
|
2.72
|
100080-1
|
Endothelial cell area.max
|
Area
|
Pt
|
Cornea.right
|
Qn
| null |
EYE.SPECULAR MICROSCOPY
| 2 |
Right cornea Endothelial cell area.max
| null | null |
TRIAL
|
2.72
|
2.72
|
10008-1
|
R wave duration.lead V5
|
Time
|
Pt
|
Heart
|
Qn
| null |
EKG.MEAS
| 2 |
R wave duration in lead V5
| null | null |
ACTIVE
|
1.0i
|
2.48
|
100081-9
|
Endothelial cell area.max
|
Area
|
Pt
|
Cornea.left
|
Qn
| null |
EYE.SPECULAR MICROSCOPY
| 2 |
Left cornea Endothelial cell area.max
| null | null |
TRIAL
|
2.72
|
2.72
|
100082-7
|
Endothelial cell area.mean
|
Area
|
Pt
|
Cornea.right
|
Qn
| null |
EYE.SPECULAR MICROSCOPY
| 2 |
Right cornea Endothelial cell area.mean
| null | null |
TRIAL
|
2.72
|
2.72
|
100083-5
|
Endothelial cell area.mean
|
Area
|
Pt
|
Cornea.left
|
Qn
| null |
EYE.SPECULAR MICROSCOPY
| 2 |
Left cornea Endothelial cell area.mean
| null | null |
TRIAL
|
2.72
|
2.72
|
100084-3
|
Cell area.standard deviation
|
Area
|
Pt
|
Cornea.right
|
Qn
| null |
EYE.SPECULAR MICROSCOPY
| 2 |
Right cornea Cell area.standard deviation
| null | null |
TRIAL
|
2.72
|
2.72
|
100085-0
|
Cell area.standard deviation
|
Area
|
Pt
|
Cornea.left
|
Qn
| null |
EYE.SPECULAR MICROSCOPY
| 2 |
Left cornea Cell area.standard deviation
| null | null |
TRIAL
|
2.72
|
2.72
|
100086-8
|
Analysis method
|
Type
|
Pt
|
Cornea.right
|
Nom
| null |
EYE.SPECULAR MICROSCOPY
| 2 |
Right cornea Type of Analysis method by Specular microscopy
| null | null |
TRIAL
|
2.72
|
2.72
|
100087-6
|
Toxocara canis 24-35kD Ab.IgG
|
PrThr
|
Pt
|
Ser
|
Ord
| null |
MICRO
| 1 |
Toxocara canis 24-35kD IgG Ab [Presence] in Serum by Immunoblot
| null | null |
ACTIVE
|
2.72
|
2.72
|
100088-4
|
Taenia solium larva Ab bands panel
|
-
|
Pt
|
Ser
|
-
| null |
PANEL.MICRO
| 1 |
Taenia solium larva Ab bands panel - Serum by Immunoblot
| null | null |
ACTIVE
|
2.72
|
2.72
|
100089-2
|
Taenia solium larva 6-8kD Ab
|
PrThr
|
Pt
|
Ser
|
Ord
| null |
MICRO
| 1 |
Taenia solium larva 6-8kD Ab [Presence] in Serum by Immunoblot
| null | null |
ACTIVE
|
2.72
|
2.72
|
1000-9
|
DBG Ab
|
PrThr
|
Pt
|
Ser/Plas^BPU
|
Ord
| null |
BLDBK
| 1 |
DBG Ab [Presence] in Serum or Plasma from Blood product unit
| null | null |
ACTIVE
|
1.0
|
2.56
|
100090-0
|
Taenia solium larva 45kD Ab
|
PrThr
|
Pt
|
Ser
|
Ord
| null |
MICRO
| 1 |
Taenia solium larva 45kD Ab [Presence] in Serum by Immunoblot
| null | null |
ACTIVE
|
2.72
|
2.72
|
100091-8
|
Trypanosoma cruzi Ab
|
ACnc
|
Pt
|
Ser
|
Qn
| null |
MICRO
| 1 |
Trypanosoma cruzi Ab [Units/volume] in Serum by Immunoassay
| null | null |
ACTIVE
|
2.72
|
2.72
|
End of preview. Expand
in Data Studio
README.md exists but content is empty.
- Downloads last month
- 21